Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Notice of Participation of the Food and Drug Administration in PAR-22-167, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) ✔ NOT-TR-24-005 11/02/2023 Notice of Information
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional) ✔ PAR-24-054 RC2 11/07/2023 09/14/2026 NA
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) ✘ PAR-24-046 R21 10/20/2023 11/19/2024 NA
Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) ✔ NOT-TR-22-016 03/02/2022 Notice of Intent to Publish
Notice of Change in Funding Opportunity Description and Application and Submission Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
✔ NOT-TR-22-026 03/21/2022 Notice of Change to Funding Opportunity
Notice of NCATS Withdrawal from Participation in PAR-18-690, Innovative Therapies and Tools for Screenable Disorders in Newborns (R03 Clinical Trial Optional) ✔ NOT-TR-20-023 04/21/2020 Notice of Change to Funding Opportunity
Notice to Extend the Expiration Date for PAR-18-332 "Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)" ✔ NOT-TR-20-026 04/27/2020 Notice of Change to Funding Opportunity
Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need ✔ NOT-TR-20-018 04/27/2020 Notice of Change to Funding Opportunity
Notice to Extend the Expiration Date for PAR-17-465 "Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)" ✔ NOT-TR-20-025 04/28/2020 Notice of Change to Funding Opportunity
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) ✘ PAR-23-171 X01 04/10/2023 05/15/2025 NA
Showing Row 121 to 130 of 437

Last updated on June 12, 2026